Spinal Fusion News and Research RSS Feed - Spinal Fusion News and Research

Benvenue Medical's Luna 360 System receives FDA clearance for spinal fusion treatment of DDD

Benvenue Medical's Luna 360 System receives FDA clearance for spinal fusion treatment of DDD

Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, today announced that the company's Luna 360 Interbody Fusion System has received 510(k) clearance from the U.S. Food and Drug Administration for spinal fusion treatment of symptomatic degenerative disc disease (DDD). [More]
University of Vermont Medical Center recognized with 2014 Partnership in Prevention Award

University of Vermont Medical Center recognized with 2014 Partnership in Prevention Award

The U.S. Department of Health and Human Services, the Association for Professionals in Infection Control and Epidemiology, and the Society for Healthcare Epidemiology of America today recognized the University of Vermont Medical Center with the 2014 Partnership in Prevention Award for achieving sustainable improvements toward eliminating healthcare-associated infections (HAIs). [More]
DePuy Synthes releases ViviGen Cellular Bone Matrix for repairing musculoskeletal defects

DePuy Synthes releases ViviGen Cellular Bone Matrix for repairing musculoskeletal defects

DePuy Synthes Companies of Johnson & Johnson, in collaboration with LifeNet Health, today announced the introduction of ViviGen Cellular Bone Matrix, a differentiated cellular allograft for the repair or reconstruction of musculoskeletal defects. [More]
DePuy Synthes releases ViviGen Cellular Bone Matrix for repairing musculoskeletal defects

DePuy Synthes releases ViviGen Cellular Bone Matrix for repairing musculoskeletal defects

DePuy Synthes Companies of Johnson & Johnson, in collaboration with LifeNet Health®, today announced the introduction of ViviGen™ Cellular Bone Matrix, a differentiated cellular allograft for the repair or reconstruction of musculoskeletal defects. [More]
Amedica, Spinal Kinetics sign multi-year OEM agreement for silicon nitride spinal implants

Amedica, Spinal Kinetics sign multi-year OEM agreement for silicon nitride spinal implants

Amedica Corporation, a biomaterial company that has developed silicon nitride ceramics as a material platform to manufacture and commercialize orthopedic implants, is pleased to announce that it has entered into a multi-year original equipment manufacturer (OEM) agreement with Spinal Kinetics, a leading innovator of advanced spinal implant technologies. [More]
MEDICREA receives FDA clearance for world’s first patient-specific spinal osteosynthesis rod

MEDICREA receives FDA clearance for world’s first patient-specific spinal osteosynthesis rod

The MEDICREA Group, a company that specializes in the development of personalized implants produced for a patient’s specific need in the treatment of spinal pathologies, today announced the company has received 510(k) clearance from the U.S. Food and Drug Administration for UNiD, the world’s first patient-specific spinal osteosynthesis rod. [More]
Amedica, Spinal Kinetics sign strategic agreement for silicon nitride spinal interbody fusion devices

Amedica, Spinal Kinetics sign strategic agreement for silicon nitride spinal interbody fusion devices

Amedica Corporation, a biomaterial company that has developed silicon nitride ceramics as a material platform to manufacture and commercialize orthopaedic implants, is pleased to announce that it has entered into a multi-year private labeling agreement with Spinal Kinetics, a leading innovator of advanced artificial spinal disc technology. [More]
Basic yoga pose reduces idiopathic scoliosis curves for adolescent, adult patients

Basic yoga pose reduces idiopathic scoliosis curves for adolescent, adult patients

A basic yoga pose, done for an average of only 1.5 minutes a day, six days a week for two months, reduced idiopathic scoliosis curves for adolescent and adult patients an average of 32% in the first peer-reviewed published clinical trial studying yoga for the reduction of scoliosis curves. [More]

Amedica releases Valeo II TL silicon nitride interbody fusion devices

Amedica Corporation, a commercial biomaterial company focused on silicon nitride ceramics as a material platform to develop, manufacture and sell novel medical devices, is pleased to announce the release of its second generation silicon nitride transforaminal lumbar (TL) interbody fusion device. [More]
New spinal fixation technique: an interview with Dr. Ian Armstrong, Medical Director, Southern California Spine Institute

New spinal fixation technique: an interview with Dr. Ian Armstrong, Medical Director, Southern California Spine Institute

Traditionally, the most commonly used medical devices for spinal fusion procedures have been pedicle screws and rods, and interbody cages or spacers. Each are coupled with bone grafts and limit movement while the area being fused heals. [More]
Mortality rates decrease for hip and knee replacement surgeries in older patients

Mortality rates decrease for hip and knee replacement surgeries in older patients

Over the past decade, a greater number of patients, age 80 and older, are having elective orthopaedic surgery. [More]
Anti-clotting treatment not needed for all kids who undergo spine operations

Anti-clotting treatment not needed for all kids who undergo spine operations

Blood clots occur so rarely in children undergoing spine operations that most patients require nothing more than vigilant monitoring after surgery and should be spared risky and costly anti-clotting medications, according to a new Johns Hopkins Children's Center study. [More]
St. Mary's Medical Center honored with Healthgrades 2014 Women's Health Excellence Award

St. Mary's Medical Center honored with Healthgrades 2014 Women's Health Excellence Award

Dignity Health St. Mary's Medical Center has received the 2014 Women's Health Excellence Award from Healthgrades, the leading online resource for comprehensive information about physicians and hospitals. [More]
First Edition: February 25, 2014

First Edition: February 25, 2014

Today's headlines include stories exploring the political dynamics governors face regarding the health law's Medicaid expansion. [More]
Sedation before nerve block significantly increases false-positive results, shows study

Sedation before nerve block significantly increases false-positive results, shows study

New research suggests that sedating patients before a nerve block needed to diagnose or treat chronic pain increases costs, risks and unnecessary surgeries, and sedation does nothing to increase patient satisfaction or long-term pain control. [More]
DePuy Synthes Spine signs representative agreement for marketing LifeNet Health's cellular allografts

DePuy Synthes Spine signs representative agreement for marketing LifeNet Health's cellular allografts

DePuy Synthes Spine and DePuy Synthes Biomaterials, divisions of DePuy Orthopaedics, Inc., announced today they have entered into an exclusive worldwide representative agreement for the marketing and promotion of a new cellular allograft product developed by LifeNet Health, a world leader in allograft bio-implants and cellular therapies. [More]
DePuy Synthes Spine announces the U.S. launch of new tissue implant for spine fusion surgery

DePuy Synthes Spine announces the U.S. launch of new tissue implant for spine fusion surgery

DePuy Synthes Spine, in collaboration with DePuy Synthes Biomaterials, announced today the U.S. launch of CONFORM SHEET, a hydrated, pliable and totally demineralized cancellous bone matrix that fills voids during posterolateral spinal fusion surgery and provides a natural scaffold for new bone formation. [More]

DePuy Synthes develops CONFORM SHEET allograft implant for spinal fusion surgery

DePuy Synthes Spine, in collaboration with DePuy Synthes Biomaterials, announced today the U.S. launch of CONFORM SHEET™, a hydrated, pliable and totally demineralized cancellous bone matrix that fills voids during posterolateral spinal fusion surgery and provides a natural scaffold for new bone formation. [More]
Research roundup: Long-term care use varies dramatically by state; health spending slowdown explained

Research roundup: Long-term care use varies dramatically by state; health spending slowdown explained

In 2012, about 58,500 paid, regulated long-term care services providers served about 8 million people in the United States. Long-term care services were provided by 4,800 adult day services centers, 12,200 home health agencies, 3,700 hospices, 15,700 nursing homes, and 22,200 assisted living and similar residential care communities. Each day in 2012, there were 273,200 participants enrolled in adult day services centers, 1,383,700 residents in nursing homes, and 713,300 residents in residential care communities; in 2011, about 4,742,500 patients received services from home health agencies, and 1,244,500 patients received services from hospices. Provider sectors differed in ownership, and average size and supply varied by region (Harris-Kojetin et al., 12/12). [More]
Research paper provides first evidence-based recommendations for using PRP in orthopaedic care

Research paper provides first evidence-based recommendations for using PRP in orthopaedic care

Platelet-rich plasma (PRP) has grabbed headlines in recent years for its role in helping some of sports' biggest stars return to play following injury -including golfer Tiger Woods, Super Bowl winner Hines Ward and NBA legend Kobe Bryant. [More]